Highlights of Ophthalmology

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  52 (2024)
Volume  51 (2023)
Volume  50 (2022)
Volume  49 (2021)
Volume  48 (2020)
Volume  47 (2019)
Volume  46 (2018)
Volume  45 (2017)
Volume  44 (2016)
Volume  43 (2015)
Volume  42 (2014)
Volume  41 (2013)
Volume  40 (2012)
Volume  39 (2011)
Volume  38 (2009)
Related articles

VOLUME 50 , ISSUE 5ESP ( October, 2022 ) > List of Articles

Manejo Práctico del Paciente con Glaucoma Avanzado

J. Alejo Peyret

Keywords : Glaucoma avanzado, progresión, tratamiento, manejo

Citation Information : Peyret JA. Manejo Práctico del Paciente con Glaucoma Avanzado. 2022; 50 (5ESP):4-11.

DOI: 10.5005/hos-10101-50501

Published Online: 29-09-2022

Copyright Statement:  Copyright © 2022; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

El glaucoma es una enfermedad crónica que debemos evaluar, evolucionar en el tiempo y tratar. El tratamiento previene la mayor pérdida de fibras nerviosas del nervio óptico. En el glaucoma avanzado estas premisas se deben cumplir, pero sin margen de error por el gran daño que el nervio presenta. Los estudios diagnósticos y evolutivos tienen sus características al presentar tan pocas fibras nerviosas. Usaremos los mismos estudios, pero enfocados a estudiar la isla central de visión. Y por supuesto, el tratamiento debe ser más agresivo para poder cumplir con la premisa que el daño no aumente. Tiene una exigencia mayor por la necesidad de presiones intraoculares (PIOs) bajas y constantes. Diversas fallas en el manejo del glaucoma a nivel social hacen que todavía haya personas que se queden ciegas por esta enfermedad. Son fundamentales los controles como el tratamiento para prevenir el mayor daño del nervio y la ceguera.

PDF Share
  1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006;90:262–7.
  2. Heijl A, Leske MC, Bengtsson B, et al. Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002;120:1268–79.
  3. Gordon MO, Kass MA. Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study: design and baseline description of the participants. Arch Ophthalmol 1999;117:573–83.
  4. European Glaucoma Society. Terminology and guidelines for glaucoma. 5° edición. 2020. Cap. II.3.3.1.
  5. Susanna R Jr, Vessani RM, Sakata L, Zacarias LC, Hatanaka M. The relation between intraocular pressure peak in the water drinking test and visual field progression in glaucoma. Br J Ophthalmol 2005; 89:1298–1301.
  6. Medeiros FA, Pinheiro A, Moura FC, Leal BC, Susanna R Jr. Intraocular pressure fluctuations in medical versus surgically treated glaucomatous patients. J Ocul Pharmacol Ther. 2002; 18: 489 – 498.
  7. Weijland, A, Frankhauser, F, Bebie, H y Flammer, J. Automated Perimetry. Visual Field Digest. 2004. 5a edición. Cap 2.2, pag 14.
  8. Sung MS, Heo H, Park SW.J. Structure-function Relationship in Advanced Glaucoma After Reaching the RNFL Floor. Glaucoma. 2019 Nov;28(11):1006-1011.
  9. Nouri-Mahdavi K, Mohammadzadeh V, Rabiolo A, Edalati K, Caprioli J, Yousefi S. Prediction of Visual Field Progression from OCT Structural Measures in Moderate to Advanced Glaucoma. Am J Ophthalmol. 2021 Jun;226:172-181.
  10. Shin, JW, Sung, KR, Lee, GC, Durbin, MK, Cheng, D. Ganglion Cell-Inner Plexiform Layer Change Detected by Optical Coherence Tomography Indicates Progression in Advanced Glaucoma. Ophthalmology 2017 Oct;124(10):1466-1474.
  11. AGIS Investigators. AGIS 14: Distinguishing Progression of Glaucoma from VF Fluctuations. Ophthalmology Nov 2004;111 (11): 2109 – 2116.
  12. AGIS investigators. AGIS 7: The Relationship Between Control of Intraocular Pressure and Visual Field Deterioration. Am J Ophthalmol 2000;130:429–440.
  13. AGIS investigators. AGIS 12. Baseline Risk Factors for Sustained Loss of Visual Field and Visual Acuity in Patients with Advanced Glaucoma. Am J Ophthalmol 2002;134: 499 –512.
  14. Agarwal HC, Sihota R, Das C, et al. Role of argon laser trabeculoplasty as primary and secondary therapy in open angle glaucoma in Indian patients British Journal of Ophthalmology 2002;86:733-736.
  15. Lee, AC, Mosaed, S, Weinreb, RN, Kripke, DF, Liu, JHK. Effect of Laser Trabeculoplasty on Nocturnal Intraocular Pressure in Medically Treated Glaucoma Patients. Ophthalmology 2007; 114 (4):666-670.
  16. Konstas, Anastasios G.P. et al. 24-Hour Intraocular Pressure Control with Maximum Medical Therapy Compared with Surgery in Patients with Advanced Open-Angle Glaucoma. Ophthalmology, Volume 113, Issue 5, 761 – 765.
  17. Wilensky JT, Zeimer RC, Gieser DK, Kaplan BH. The effects of glaucoma filtering surgery on the variability of diurnal intraocular pressure. Trans Am Ophthalmol Soc. 1994;92:377-81.
  18. Bettin P, Khaw PT. Enhanced Trabeculectomy: The Moorfields Safer Surgery System. Glaucoma Surgery. 2Nd revised and extended edition. Dev Ophthalmol. Basel, Karger, 2017, vol 59, pp 15–35.
  19. Topouzis, F. Procedural Treatments: Surgery in End-Stage Glaucoma, en J. A. Giaconi et al. (eds.), Pearls of Glaucoma Management, Ed. Springer, 2010, Cap. 42, pag 323- 330.
  20. Awai M, Koga T, Inatani M, Inoue T, Tanihara H. Stability of the central visual field after modern trabeculectomy techniques in eyes with advanced glaucoma. Jpn J Ophthalmol. 2007 Mar-Apr;51(2):116-20.
  21. Martinez JA, Brown RH, Lynch MG, et al. (1993) Risk of postoperative visual loss in advanced glaucoma. Am J Ophthalmol 115:332–337.
  22. Lichter PR, Ravin JG (1974) Risks of sudden visual loss after glaucoma surgery. Am J Ophthalmol 78:1009–1013.
  23. Moster MR y Moster ML. Wipe-Out: A Complication of Glaucoma Surgery or Just a Blast From the Past? Am J Ophthalmol 2005;140:705-706.
  24. Law SK, Nguyen AM, Coleman AL, Caprioli J. Severe loss of central vision in patients with advanced glaucoma undergoing trabeculectomy. Arch Ophthalmol. 2007 Aug;125(8):1044-50.
  25. Leleu, I, Penaud, B, Blumen-Ohana, E, Rodallec, T, Adam, R, Laplace, O, Akesbi, J, Nordmann, JP. Risk assessment of sudden visual loss following non-penetrating deep sclerectomy in severe and end-stage glaucoma. Eye (2019) 33:902–909.
  26. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 11. Risk Factors for Failure of Trabeculectomy and Argon Laser Trabeculoplasty. Am J Ophthalmol 2002; 134: 481-489.
  27. Nollett, Claire L. et al. High Prevalence of Untreated Depression in Patients Accessing Low-Vision Services. Ophthalmology, Vol. 123, Issue 2, 440 – 441.
  28. Evans, JR., Fletcher, AE, Wormald, RPL. Depression and Anxiety in Visually Impaired Older People. Ophthalmology, Vol. 114, Issue 2, 283 – 288.
  29. Lee, JS; Park, S; Seong, GJ y col. Long-term Intraocular Pressure Fluctuation Is a Risk Factor for Visual Field Progression in Advanced Glaucoma. Journal of Glaucoma, May 2022 – Vol. 31 (5):310-316.
  30. Islamaj, E, Wubbels, RJ, de Waard, PWT. Primary baerveldt versus trabeculectomy study after 5 years of follow-up. Acta Ophthalmol. 2020 Jun; 98(4): 400–407.
  31. Gedde, SJ, Heuer, DH, Parrish II, R. y the Tube Versus Trabeculectomy Study Group. Review of Results from the Tube Versus Trabeculectomy (TVT) Study. Curr Opin Ophthalmol. 2010 Mar; 21(2): 123–128.
  32. Salimi, A, Watt, H, Harasymowycz, P. Long-term outcomes of two first generation trabecular micro-bypass stents (iStent) with phacoemulsification in primary open angle glaucoma: eight year results. Eye Vis (Lond) 2021; 8: 43.
  33. Budenz, D y col. Five-year Treatment Outcomes in the Ahmed Baerveldt Comparison Study Ophthalmology. 2015 Feb; 122(2): 308–316.
  34. Meyer, AM y col. Attaining Intraocular Pressure of 10 mm Hg: Comparison of Tube and Trabeculectomy Surgery in Pseudophakic Primary Glaucoma Eyes. Asia Pac J Ophthalmol (Phila) 2019 Nov-Dec; 8(6): 489–500.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.